Clinical Trial FAQs

1 guide on how clinical trials in China actually work for patients and families. Compiled by the CMDN editorial team from public NMPA filings and clinical guidelines; not a substitute for advice from your treating physician.

Can International Patients Join Interventional Myeloma Clinical Trials in China?

Regulatory Reality · International Patient Guide

An independent, factual guide on why foreign nationals and international myeloma patients almost never qualify for interventional clinical trials in mainland China. Learn about strict Human Genetic Resources (HGRAC) regulations, domestic residency barriers, and how to identify misleading medical intermediary claims.

Read the guide

Back to the clinical trials index